Social Recovery Therapy in improving activity and social outcomes in early psychosis: Current evidence and longer term outcomes

David Fowler, Jo Hodgekins, Paul French, David Fowler, Jo Hodgekins, Paul French

Abstract

Background: Social Recovery Therapy (SRT) is a cognitive behavioural therapy which targets young people with early psychosis who have complex problems associated with severe social disability. This paper provides a narrative overview of current evidence for SRT and reports new data on a 2year follow-up of participants recruited into the Improving Social Recovery in Early Psychosis (ISREP) trial.

Method: In the ISREP study 50 participants (86%) were followed up at 2years, 15months post treatment. The primary outcome was engagement in paid work, assessed using the Time Use Survey. Engagement in education and voluntary work were also assessed. In addition, the Positive and Negative Syndrome Scales (PANSS) and the Beck Hopelessness Scale (BHS) were administered.

Results: 25% of individuals with non-affective psychosis in the treatment group had engaged in paid work at some point in the year following the end of therapy, compared with none of the control group. Data from the PANSS and BHS suggested no worsening of symptoms and an indication that gains in hope were maintained over the 15month period following the end of therapy.

Conclusion: Social Recovery Therapy is a promising psychological intervention which may improve social recovery in individuals with early psychosis. The new data reported in this paper shows evidence of gains in engagement in paid employment outcomes that persisted 15months beyond the period of active intervention.

Keywords: Cognitive behaviour therapy; Psychosis; Social recovery.

Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
CONSORT diagram of flow of participants through the trial.

References

    1. Barton G.R., Hodgekins J., Mugford M., Jones P.B., Croudace T., Fowler D. Cognitive behaviour therapy for improving social recovery in psychosis: cost-effectiveness analysis. Schizophr. Res. 2009;112:158–163.
    1. Beck A.T., Steer R.A. The Psychological Corporation; San Antonio, TX: 1988. Beck Hopelessness Scale Manual.
    1. Birchwood M., Lester H., McCarthy L., Jones P.B., Fowler D., Amos T., Freemantle N., Sharma V., Lavis A., Singh S., Marshall M. The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics. Early Interv. Psychiatry. 2014;8(1):59–67.
    1. Bond G.R., Drake R.E., Campbell K. Effectiveness of individual placement and support supported employment for young adults. Early Interv. Psychiatry. 2014;10(4):300–307.
    1. Bond G.R., Drake R.E., Luciano A. Employment and educational outcomes in early intervention programmes for early psychosis: a systematic review. Epidemiol. Psychiatr. Sci. 2015;24(5):1–12.
    1. Craig T., Shepherd G., Rinaldi M., Smith J., Carr S., Preston F., Singh S. Vocational rehabilitation in early psychosis: cluster randomised trial. Br. J. Psychiatry. 2014;205:145–150.
    1. Fleischhacker W.W., Arango C., Arteel P., Barnes T.R.E., Carpenter W., Duckworth K., Galderisi S., Halpern L., Knapp M., Marder S.R., Moller M., Sartorius N., Woodruff P. Schizophrenia – time to commit to policy change. Schizophr. Bull. 2014;40:S165–S194.
    1. Fowler D., Hodgekins J., Howells L., Millward M., Ivins A., Taylor G., Hackmann C., Hill K., Bishop N., Macmillan I. Can targeted early intervention improve recovery in psychosis? A historical control evaluation of the effectiveness of different models of early intervention service provision in Norfolk 1998–2007. Early Interv. Psychiatry. 2009;3(4):282–288.
    1. Fowler D., Hodgekins J., Painter M., Reilly T., Crane C., Macmillan I., Mugford M., Croudace T., Jones P.B. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC trial platform study (improving social recovery from early psychosis) Psychol. Med. 2009;39:1627–1636.
    1. Fowler D., Hodgekins J., Arena K., Turner R., Lower R., Wheeler K., Corlett E., Reilly T., Wilson J. Early detection and psychosocial intervention for young people who are at risk of developing long term socially disabling severe mental illness: should we give equal priority to functional recovery and complex emotional dysfunction as to psychotic symptoms? Clin. Neuropsychiatry. 2010;7(2):63–71.
    1. Fowler D., French P., Hodgekins J., Lower R., Turner R., Burton S., Wilson J. CBT to Address and Prevent Social Disability in Early and Emerging Psychosis. In: Steel C., editor. CBT for Schizophrenia: Evidence Based Interventions and Future Directions. John Wiley & Sons; 2013.
    1. Fowler D., French P., Banerjee R., Barton G., Berry C., Byrne R., Clarke T., Fraser R., Gee B., Greenwood K., Notley C., Parker S., Shepstone L., Wilson J., Yung A.R., Hodgekins J. Prevention and treatment of long term social disability amongst young people with emerging severe mental illness with Social Recovery Therapy (the PRODIGY trial): study protocol for a randomized controlled trial. Trials. 2017;18:315.
    1. Fowler D., Hodgekins J., French P., Marshall M., Freemantle N., McCrone P., Everard L., Lavis A., Jones P., Amos T., Singh S., Sharma V., Birchwood M. Sustaining and enhancing positive engagement and recovery in first episode psychosis using Social Recovery Therapy in combination with Early Intervention Services (the SUPEREDEN3 trial): a randomised controlled trial. Lancet Psychiatry. 2017 (in press)
    1. Gershuny J. Centre for Time Use Research; Oxford: 2011. Time Use Surveys and the Measurement of National Well Being.
    1. Hafner H., an der Heiden W. The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur. Arch. Psychiatry Clin. Neurosci. 1999;249:14–26.
    1. Harrison G., Croudace T., Mason P., Glazebrook C., Medley I. Predicting the long-term outcome of schizophrenia. Psychol. Med. 1996;26:697–705.
    1. Hodgekins J., Fowler D. CBT and recovery from psychosis in the ISREP trial: mediating effects of hope and positive beliefs on activity. Psychiatr. Serv. 2010;61:321–324.
    1. Hodgekins J., Birchwood M., Christopher R., Marshall M., Coker S., Everard L., Lester H., Jones P.B., Amos T., Singh S., Sharma V., Freemantle N., Fowler D. Investigating trajectories of social recovery in individuals with first-episode psychosis: a latent class growth analysis. Br. J. Psychiatry. 2015;207(6):536–543.
    1. Hodgekins J., French P., Birchwood M., Mugford M., Christopher R., Marshall M., Everard L., Lester H., Jones P.B., Amos T., Singh S., Sharma V., Morrison A.P., Fowler D. Comparing time use as a measure of social functioning in individuals at different stages of psychosis and in a non-clinical comparison group. Schizophr. Res. 2015;161:188–193.
    1. Jaaskeelainen E., Juola P., Hirvonen N., McGrath J.J., Saha S., Isohanni M., Veijola J., Miettunen J. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr. Bull. 2013;39:1296–1306.
    1. Kam S.M., Singh S.P., Upthegrove R. What needs to follow early intervention? Predictors of relapse and functional recovery following first-episode psychosis. Early Interv. Psychiatry. 2013;9(4):279–283.
    1. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987;13:261–276.
    1. Kern R.S., Glynn S.M., Horan W.P., Marder S.R. Psychosocial treatments to promote functional recovery in schizophrenia. Schizophr. Bull. 2009;35:347–361.
    1. Killackey E., Jackson H., Fowler D., Nuechterlin K.H. Enhancing work functioning in early psychosis. In: Jackson H., McGorry P., editors. The Recognition and Management of Early Psychosis: A Preventative Approach. Cambridge University Press; 2009.
    1. Law H., Morrison A.P. Recovery in psychosis: a Delphi study with experts by experience. Schizophr. Bull. 2014;40:1347–1355.
    1. Lenior M.E., Dingemans P.M., Linszen D.H., de Haan L., Schene A.H. Social functioning and the course of early-onset schizophrenia: five-year follow-up of a psychosocial intervention. Br. J. Psychiatry. 2001;179:53–58.
    1. Martinez-Aran A., Vieta E., Torrent C., Sanchez-Moreno J., Goikolea J., Salamero M., Malhi G., Gonzalez-Pinto A., Daban C., Alvarez-Grandi S., Fountoulakis K., Kaprinis G., Tabares-Seisdedos R., Ayuso-Mateos J. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9:103–113.
    1. Modini M., Tan L., Brinchmann B., Wang M., Killackey E., Glozier N., Mykletun A., Harvey S.B. Supported employment for people with severe mental illness: systematic review and meta-analysis of the international evidence. Br. J. Psychiatry. 2016;209:14–22.
    1. Mueser K.T., Salyers M.P., Mueser P.R. A prospective analysis of work in schizophrenia. Schizophr. Bull. 2001;27:281–296.
    1. National Institute for Health and Care Excellence (NICE) NICE Clinical Guideline 178. NICE; London: 2014. Psychosis and schizophrenia in adults: treatment and management.
    1. Notley C., Christopher R., Hodgekins J., Byrne R., French P., Fowler D. Participant views on involvement in a trial of social recovery cognitive-behavioural therapy. Br. J. Psychiatry. 2015;206(2):122–127.
    1. Walters S.J., Bonacho dos Anjos Henriques-Cadby I., Bortolami O., Flight L., Hind D., Jacques R.M., Knox C., Nadin B., Rothwell J., Surtees M., Julious S.A. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom health technology assessment programme. BMJ Open. 2017;e015276:7.
    1. Wiersma D., Wanderling J., Dragomirecka E., Ganev K., Harrison G., an der Heiden W., Nienhuis F.J., Walsh D. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol. Med. 2000;30:1155–1167.
    1. Wykes T., Steel C., Everitt B., Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr. Bull. 2008;34:523–537.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi